Stimulation of motility of human renal cell carcinoma by SPARC/osteonectin/BM-40 associated with type IV collagen

Invasion and Metastasis

Volumn 18, Issue 2, 1999, Pages 105-114

  Kato, Yasumasa ^a   Sakai, Naoki ^b   Baba, Masaya ^b   Kaneko, Shigeki ^b   Kondo, Keiichi ^b   Kubota, Yoshinobu ^b   Yao, Masahiro ^b   Shuin, Taro ^c   Saito, Shigeru ^a   Koshika, Shinri ^a   Kawase, Toshio ^a   Miyagi, Yohei ^b   Aoki, Ichiro ^b   Nagashima, Yoji ^b  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cell motility; Renal cell carcinoma; SPARC osteonection BM 40; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; OSTEONECTIN;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CHEMOTAXIS; FILTER; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NONHUMAN; OSTEOSARCOMA CELL; RAT;

ANIMALS; BONE NEOPLASMS; CARCINOMA, RENAL CELL; CELL MOVEMENT; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG SYNERGISM; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; OSTEONECTIN; OSTEOSARCOMA; RATS; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED;

EID: 0344223459     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024503     Document Type: Article

References (38)

1. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR: Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981;26:99-105.
2. Dziadek M, Paulsson M, Aumailley M, Timpl R: Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. Eur J Biochem 1986;161:455-464.
3. Lane TF, Sage EH: The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994;8:163-173.
4. Mayer U, Aumailley M, Mann K, Timpl R, Engel J: Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur J Biochem 1991;198:141-150.
5. Iruela-Arispe ML, Diglio CA, Sage EH: Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arterioscler Thromb 1991;11:805-815.
6. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH: SPARC is a source of copperbinding peptides that stimulate angiogenesis. J Cell Biol 1994; 125:929-943.
7. Iruela-Arispe ML, Lane TF, Redmond D, Reilly M, Bolender RP, Kavanagh TJ, Sage EH: Expression of SPARC during development of the chicken chorioallantoic membrane: Evidence for regulated proteolysis in vivo. Mol Biol Cell 1995; 6:327-343.
8. 2+-binding EF-hand sequence. J Cell Biochem 1995;57:127-140.
9. 2+-dependent binding to the extracellular matrix. J Cell Biol 1989;109:341-356.
10. Hasselaar P, Sage EH: SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 1992;49:272-283.
11. Goldblum SE, Ding X, Funk SE, Sage EH: SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci USA 1994;91:3448-3452.
12. Bellahcene A, Castronovo V: Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 1995;146:95-100.
13. Graham JD, Balleine RL, Milliken JS, Bilous AM, Clarke CL: Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content. Eur J Cancer 1997;33:1654-1660.
14. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P, Gespach C: Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 1995;64:70-75.
15. Ledda F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OL: The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 1997;108:210-214.
16. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM: Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 1995;43:791-800.
17. Colombo MP, Biondi G, Galasso D, Baracetti P, Howe CC, Parmiani G: Osteonectin transcript and metastatic behavior in v-Ki-ras transformed fibroblasts. Int J Cancer 1989;suppl 4:76-77.
18. Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL: Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 1997;3:171-176.
19. Tremble PM, Lane TF, Sage EH, Werb Z: SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 1993;121:1433-1444.
20. Mason IJ, Murphy D, Munke M, Francke U, Elliott RW, Hogan BL: Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11. EMBO J 1986;5:1831-1837.
21. Gudas LJ, Grippo JF, Kim KW, Larosa GJ, Stoner CM: The regulation of the expression of genes encoding basement membrane proteins during the retinoic acid-associated differentiation of murine teratocarcinoma cells. Ann NY Acad Sci 1990; 580:245-251.
22. Machida J, Koshino T, Yoshida N, Miruma T, Miyagi Y, Aoki I, Watanabe S, Kuchino Y, Misugi K, Nagashima Y: Establishment of two rat osteosarcoma cell lines (YROS-1 and YROS-2) induced by radioactive phosphorus. Pathol Res Pract 1995;191:478-485.
23. 32P labeling of CDP-diacylglycerol in c-myc gene expressed human kidney cancer cells. FEBS Lett 1987;212: 159-162.
24. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-3245.
25. Kato Y, Nakayama Y, Umeda M, Miyazaki K: Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse meatastatic melanoma cell lines. J Biol Chem 1992;267:11424-11430.
26. Kamihagi K, Katayama M, Ouchi R, Kato I: Osteonectin/SPARC regulates cellular secretion rates of fibronectin and laminin extracellular matrix proteins. Biochem Biophys Res Commun 1994;200:423-428.
27. Kelm R Jr, Mann KG: The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation. J Biol Chem 1991;266:9632-9639.
28. Hasselaar P, Loskutoff DJ, Sawdey M, Sage EH: SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. J Biol Chem 1991;266:13178-13184.
29. Sage H, Vernon RB, Decker J, Funk S, Iruela-Arispe ML: Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J Histochem Cytochem 1989; 37:819-829.
30. Strandjord TP, Sage EH, Clark JG: SPARC participates in the branching morphogenesis of developing fetal rat lung. Am J Respir Cell Mol Biol 1995;13:279-287.
31. Gilmour DT, Lyon GJ, Carlton MBL, Sanes JR, Cunningham JM, Anderson JR, Hogan BLM, Evans MJ, Colledge WH: Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 1998;17:1860-1870.
32. McCarthy JB, Furcht LT: Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol 1984; 98:1474-1480.
33. Furcht LT, McCarthy JB, Palm SL, Basara ML, Enenstein J: Peptide fragments of laminin and fibronectin promote migration (haptotaxis and chemotaxis) of metastatic cells. Ciba Found Symp 1984;108:130-145.
34. Taraboletti G, Roberts DD, Liotta LA: Thrombospondin-induced tumor cell migration: Haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 1987;105:2409-2415.
35. Sage H, Johnson C, Bornstein P: Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J Biol Chem 1984;259:3993-4007.
36. Nagata T, Goldberg HA, Zhang Y, Domenicucci C, Sodek J: Biosynthesis of bone proteins by fetal porcine calvariae in vitro. Rapid association of sulfated sialoproteins (secreted phosphoprotein-1 and bone sialoprotein) and chondroitin sulfate proteoglycan (CS-PGIII) with bone mineral. Matrix 1991;11:86-100.
37. Jendraschak E, Sage EH: Regulation of angiogenesis by SPARC and angiostatin: Implications for tumor cell biology. Semin Cancer Biol 1996;7:139-146.
38. Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS: SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene 1996;12:1895-1901.